Position in RGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,570,000
-$4,710,000 QoQ
Shares Held
1,500,000
+25.0% QoQ
Ownership
2.90%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integral Health Asset Management, LLC holds $1,255,592,830 across 56 Biotechnology names. RGNX ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,500,000 | $245,280,000 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $145,875,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $105,456,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,000 | $65,674,400 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,600,000 | $64,368,000 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $55,400,000 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
600,000 | $52,182,000 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
1,600,000 | $50,400,000 |
All Filings in RGNX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,570,000 | 1,500,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,280,000 | 1,200,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,615,000 | 1,100,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,747,000 | 700,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,613,750 | 925,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,957,000 | 900,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,374,750 | 1,275,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,115,000 | 950,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,013,200 | 760,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,833,750 | 325,000 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $2,987,100 | 90,000 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,452,500 | 75,000 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,305,600 | 55,000 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||